REED JOHN C 4
4 · JOHNSON & JOHNSON · Filed May 5, 2025
Insider Transaction Report
Form 4
REED JOHN C
EVP, Innovative Medicine, R&D
Transactions
- Exercise/Conversion
Restricted Share Units
2025-05-01−25,255→ 25,255 total→ Common Stock (25,255 underlying) - Tax Payment
Common Stock
2025-05-01$156.31/sh−11,002$1,719,723→ 29,795 total - Exercise/Conversion
Common Stock
2025-05-01+25,255→ 40,797 total
Footnotes (2)
- [F1]Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on May 1, 2023 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting.
- [F2]Shares withheld for payment of taxes upon vesting of RSUs.